** Shares of Amplia Therapeutics ATX.AX rise as much as 16.3% to A$0.100, posting their biggest percentage gain since Oct. 10
** Stock hits its highest level since Nov. 15
** Drug developer reports positive clinical trial results for its pancreatic cancer drug narmafotinib
** Says 35% patients show partial response in trial vs 23% in historical standard-of-care treatment
** About 6.4 mln shares change hands, compared with the 30-day average volume of around 1.6 mln
** Stock up 20.7% YTD, including session's move
(Reporting by Aaditya Govind Rao in Bengaluru)
((Aaditya.govindrao@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。